Expert commentators

Advice

The following clinicians contributed to this briefing:

Professor Andrew Beggs, professor of cancer genetics and surgery, University of Birmingham/University Hospitals Birmingham NHS Foundation Trust. Professor Beggs is chief investigator of a trial on using an artificial intelligence algorithm commissioned by NHS Test and Trace and written by Sensyne Plc.
Dr Gary Davies, hospital medical director, Chelsea and Westminster Hospital. SYNE-COV is trialled in Chelsea and Westminster Hospital. Declared no financial or direct conflicts of interest.
Dr Matthew C Frise, Consultant in Acute Medicine and Intensive Care, Royal Berkshire NHS Foundation Trust. Declared no direct conflicts of interest.
Professor Pallav Shah, consultant physician in respiratory medicine, Royal Brompton and Harefield Hospitals and Chelsea and Westminster Hospital. Did not declare any interests.

Dr Lucy Mackillop (Chief Medical Officer, Sensyne Health plc) and Dr Marcela Vizcaychipi (one of the inventors of SYNE-COV) contributed to this briefing.